ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 237677 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 237677; 2) Community: the network communities that were significantly associated with the response to NSC 237677; 3) Molecule: the relationships between components within communities and NSC 237677; 4) MDR: the compounds that were significantly associated with the NSC 237677.

NSC Compound Enrichment Correlation
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.0038671642008129 0.37519261
NSC 639187 Landomycin A 0.0038671642008129 0.57405492
NSC 663286 7-Chloro-6-N-(2-fluoroethylamino)-5,8-quinolinedione 0.0038671642008129 0.27844394
NSC 666113 Null 0.0038671642008129 0.61280554
NSC 671316 Null 0.0038671642008129 0.31105477
NSC 709100 Null 0.0038671642008129 0.35689065
NSC 709564 Null 0.0038671642008129 0.29472515
NSC 736153 Null 0.0038671642008129 0.39925568
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0038671642008129 0.23454195
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.00396536695012846 0.50301431
Total:104  Current:10    [First] [Prev] [Next] [Last]